Reset Health, a company that has created an app to connect obesity and type 2 diabetes patients with clinicians, is exploring a possible public listing on London’s stock market.
The digital health company has appointed advisors from the stockbroker Shore Capital to assist with the possible float, according to The Times, which cited City sources.
The London-based firm is reportedly considering a listing on the Aim market in a deal that could see the business valued at up to £60m and raise £15m.
It would provide another boost to London’s IPO markets just a week after the UK capital overtook Paris as Europe’s largest stock exchange.
Data has shown the cash raised from IPOs in London has slowed down significantly, as major tech companies such as Arm and Imagination have opted to list in New York.
Earlier this month shares in budget personal computer maker Raspberry Pi soared on its London debut.
Founded in 2019, Rest Health’s platform provides personalised diet and exercise plans. The company has partnerships with NHS trusts and private healthcare providers.
Reset Health did not immediately respond to UKTN’s request for comment.
A spokesperson for Reset told The Times: “Reset Health confirms that it is considering an IPO on Aim as one of a number of potential funding alternatives to support the company’s ambitious growth strategy.”
The post Reset Health considers London float in boost for the City appeared first on UKTN.
